Ahead of ASCO 2026, Illumina unveiled an early-access MRD research kit using whole-genome sequencing and DRAGEN analysis.

Bonito and DaltonTx aim to create an iterative learning loop for discovery of precision delivery systems for conjugated oligotherapeutics.

The data showed elevated levels of the metabolite αKG improved DNA repair, and blocking it made the cancer cells more sensitive to treatment.

Researchers developed PRINCE, a small-molecule-controlled CRISPR system enabling precise, long-term regulation of gene editing.

The latest update to the ESM protein language model series supports binder design and protein function mapping for therapeutic discovery.

Researchers suggest MutationProjector offers a unifying framework for connecting tumor genotypes to biological mechanisms and therapeutic outcomes.

Eli Lilly has agreed to acquire three privately-held developers of vaccines for infectious diseases for a combined up-to-$3.83 billion cash, in deals intended to expand the acquisitive pharma giant’s ...

The Copenhagen-based team is building an AI platform to target underexplored GPCRs to treat diseases once deemed undruggable.

Parabilis Medicines, the developer of drugs and antibody-drug conjugates targeting historically undruggable protein targets ...

Researchers suggest targeting mTOR activity in aggressive cancers by blocking cholesterol sensing may represent a promising ...

By developing their own functional nerves, these organoids demonstrate how engineering principles can drive biological ...

New AI‑designed miniproteins precisely modulate GPCR signaling and reveal a new screening system for targeting receptors long ...